In our results, it was revealed that Tec treatment could effectively inhibit the proliferation of HCT116 colorectal tumor cells, and the expression of PKM2, HK2, LDHA and GLUT1 protein decreased, suggesting that glycolysis might be the promising target of Tec for anti-colorectal cancer therapy. This evidence concerns the gene SLC2A1 and colorectal neoplasm.